Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
September 10, 2025Acta Anaesthesiologica Scandinavica

Methylprednisolone and Endothelial Dysfunction in Cardiac Surgery: A Pilot Randomized Trial

View Full Paper
Ask AI
Bookmark
Share

Authors

KHKatarina Winant HalenarovaErasmus HospitalDBDaniel De BackerUniversité Libre de BruxellesHNHassane NjimiUniversité Libre de Bruxelles

Discussion

Loading...

Member takes

Implication

Pilot randomized trial evaluates methylprednisolone impact on endothelial dysfunction in cardiac surgery, suggesting limited effects.

Key Points

  • Methylprednisolone had no significant impact on endothelial dysfunction markers in cardiac surgery patients.
  • Maximal post-CPB median flow-mediated dilation was 5.7% for methylprednisolone and 4.7% for placebo, with no significant difference.
  • Assessment involved a parallel-group, randomized controlled trial design focusing on endothelial reactivity and syndecan-1 levels.
  • Results indicate a correlation between syndecan-1 levels and alterations in flow-mediated dilation, highlighting glycocalyx damage implications.

Cite This Study

Halenarova et al. (2025) studied this question.

synapsesocial.com/papers/68c23f1fb210217d64794d6chttps://doi.org/10.1111/aas.70109
View Full Paper
Ask AI
Bookmark
Share